Topline results for the randomized portion of PALISADE-4 are expected in the second quarter of 2026SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage ...

Given its suite of levels that cycle in various threats, randomized weapons, resources, and perks, Saros is technically a ...

If you're on a tight schedule but still want to hop into a great shooter game, try the following titles that take less than 5 ...

Knob tweakers, assemble! Europe's most exciting synth showcase is upon us ...

Discusses BGE-102 Clinical Results and Development Strategy for Cardiovascular and Retinal Disease May 8, 2026 12:30 PM ...